(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
8.96% $ 0.414
Live Chart Being Loaded With Signals
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 161 222 |
Średni wolumen | 163 739 |
Kapitalizacja rynkowa | 10.78M |
EPS | $0 ( 2024-05-13 ) |
Następna data zysków | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.202 |
ATR14 | $0.0430 (13.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-07 | Wolf Jeffrey Alan | Buy | 2 843 137 | Stock Option (right to buy) |
2022-12-07 | Smith Edward B Iii | Buy | 101 960 | Stock Option (right to buy) |
2022-12-07 | Prendergast John K A | Buy | 203 921 | Stock Option (right to buy) |
2022-12-07 | Ostrander William L. | Buy | 490 196 | Stock Option (right to buy) |
2022-12-07 | Monahan John J | Buy | 101 960 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 24 129 486 | Sell: 659 541 |
Wolumen Korelacja
NightHawk Biosciences, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NightHawk Biosciences, Korelacja - Waluta/Towar
NightHawk Biosciences, Finanse
Annual | 2022 |
Przychody: | $5.98M |
Zysk brutto: | $-420 025 (-7.02 %) |
EPS: | $-1.710 |
FY | 2022 |
Przychody: | $5.98M |
Zysk brutto: | $-420 025 (-7.02 %) |
EPS: | $-1.710 |
FY | 2021 |
Przychody: | $2.11M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.410 |
FY | 2020 |
Przychody: | $2.95M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.630 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NightHawk Biosciences,
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. The company has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej